Form 8-K - Current report:
SEC Accession No. 0000950170-25-060586
Filing Date
2025-04-30
Accepted
2025-04-30 08:00:18
Documents
11
Period of Report
2025-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rani-20250424.htm   iXBRL 8-K 49005
  Complete submission text file 0000950170-25-060586.txt   166791

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rani-20250424.xsd EX-101.SCH 26034
13 EXTRACTED XBRL INSTANCE DOCUMENT rani-20250424_htm.xml XML 4939
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 25891073
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)